REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
01/24/2026
Back to search
Official data from USPTO
KHONDRION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/25/2026
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
10/13/2015
Registration date
01/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2023
Last transaction
01/25/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Beuningen Gld, NL
Examiner
FATHY, DOMINIC
Law office
L40
Holders and representatives
Holders
Khondrion IP B.V.
Khondrion IP B.V.
Representatives
Cynthia R. Adwere Law Office of Cynthia R. Adwere
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations and substances for the treatment of mitochondrial diseases; adhesive patches in the nature of bandages for medical purposes; adhesive patches in the nature of bandages for surgical purposes; adhesive patches incorporating a pharmaceutical preparation for use in the treatment of mitochondrial diseases; vaccines; vitaminsminerals and food supplements; dietary preparations for the treatment of mitochondrial diseasesdietary supplements; dietetic substances including foods and drinks adapted for the treatment of mitochondrial diseasesdietary food and drink mix supplements; foods for infants and invalids in the nature of dietary food supplementsfor the treatment of mitochondrial diseases; reactants for medical diagnosis; cultures of microorganisms for medical use; reactants for veterinary diagnosis; veterinary preparations for the treatment of mitochondrial diseases; cultures of microorganisms for veterinary use
Class 41
Medical education servicesconducting classes and seminars in the field of the treatment of mitochondrial diseases; medical training and teaching in the field of the treatment of mitochondrial diseases; publishing of medical publications ; organization of conferences and symposia in the field of medical science for non-business and non-commercial purposes; veterinary education servicesconducting classes and seminars in the field of the treatment of mitochondrial diseases; veterinary training and teaching in the field of the treatment of mitochondrial diseases; publishing of veterinary publications; organization of conferences and symposia in the field of veterinary research for non-business and non-commercial purposes
Class 42
Scientific research for medical purposes ; veterinary laboratory services
Class 44
Medicalhygienic and beauty care; healthcare services; provision of medical information and services ; information provided to patients and healthcare professionals relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals and vaccinesmedical diseases and disorders and related treatments via the Internet ; gene and cell therapy; medical and psychological counseling services; medical diagnostic services; veterinary services; veterinary surgical services
Publications
History of USPTO decisions and trademark events.
44 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/30/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/30/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/09/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/21/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/23/2024
INPC
INVALIDATION PROCESSED
04/23/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/12/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/13/2023
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
08/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2023
ES75
TEAS SECTION 71 & 15 RECEIVED
01/24/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/24/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/20/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/26/2017
FIMP
FINAL DISPOSITION PROCESSED
04/26/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/24/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/02/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2016
PUBO
PUBLISHED FOR OPPOSITION
11/08/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/19/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
10/03/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/03/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
10/03/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/03/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/31/2016
GNFR
FINAL REFUSAL E-MAILED
07/31/2016
CNFR
FINAL REFUSAL WRITTEN
07/31/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2016
RFNT
REFUSAL PROCESSED BY IB
02/27/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2016
RFRR
REFUSAL PROCESSED BY MPU
02/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2016
CNRT
NON-FINAL ACTION WRITTEN
02/04/2016
DOCK
ASSIGNED TO EXAMINER
02/03/2016
MAFR
APPLICATION FILING RECEIPT MAILED
01/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2016
Continuous trademark protection
Get notified about every new filing that threatens KHONDRION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.